raw materials – Page 42

API stability failure during deviation investigation – CAPA aligned to GMP expectations

Analyzing API Stability Failures through Effective Deviation Investigation In the highly regulated field of pharmaceutical manufacturing, maintaining the stability of Active Pharmaceutical Ingredients (APIs) is crucial for ensuring product safety…

Particle size variability impacts performance during incoming testing – root cause investigation framework

Understanding the Impact of Particle Size Variability on Incoming Testing Performance In pharmaceutical manufacturing, maintaining stringent quality control during the acceptance testing of raw materials is critical to ensure product…

Impurity profile drift detected during regulatory inspection – preventing batch rejection and recall

Preventing Batch Rejection and Recall from Impurity Profile Drift During Regulatory Inspections During a recent regulatory inspection, a pharmaceutical manufacturing facility detected impurity profile drift in its active pharmaceutical ingredients…

API stability failure during stability studies – regulatory impact assessment

Investigation into API Stability Failures During Stability Studies and Their Regulatory Impact API stability failures during stability studies can lead to significant challenges in pharmaceutical manufacturing, quality control, and regulatory…

Nitrosamine Contamination Risk in Raw Materials? Assessment and Control Strategies

Nitrosamine Contamination Challenges in Raw Materials and Control Solutions Nitrosamine contamination poses significant risks to pharmaceutical manufacturing processes, affecting product quality and regulatory compliance. This article addresses the common symptoms…

Material Mix-Ups Threatening Patient Safety? Traceability and Control Systems Explained

Addressing Material Mix-Ups: A Guide to Traceability and Control Systems for Pharma Professionals In the pharmaceutical manufacturing environment, material mix-ups can lead to serious regulatory violations and, more importantly, threaten…

Uncontrolled Material Changes Causing Deviations? Raw Material Change Control Strategy

Addressing Uncontrolled Changes in Raw Material: A Comprehensive Change Control Strategy In the pharmaceutical manufacturing environment, uncontrolled changes to raw materials can lead to significant deviations that jeopardize product quality…

Improper Storage Reducing Material Shelf Life? Storage Control and Monitoring Solutions

Addressing Improper Storage Impacting Material Shelf Life: Effective Storage Control and Monitoring Strategies In pharmaceutical manufacturing, the proper storage of raw materials is crucial for maintaining their integrity and ensuring…

Sampling Errors Leading to Invalid Test Results? GMP Sampling Best Practices Explained

Understanding and Addressing Raw Material Sampling Errors in Pharmaceutical Manufacturing Raw material sampling errors can lead to invalid test results, which disrupt quality control processes and can violate Good Manufacturing…

API Quality Variability Causing Batch Failures? Control Strategies for Consistent Raw Materials

Strategies for Managing API Quality Variability to Prevent Batch Failures In the pharmaceutical manufacturing environment, quality issues stemming from active pharmaceutical ingredients (APIs) can lead to significant batch failures, leading…

API Quality Variability Problems? Supplier, Testing, and Control Strategy Solutions

Addressing API Quality Variability: Solutions for Supplier, Testing, and Control Challenges The production of active pharmaceutical ingredients (APIs) is a critical aspect of pharmaceutical manufacturing, yet quality variability is an…

Raw Material Variability and Supplier Risk? Control Strategy Solutions for APIs and Excipients

Tackling Variability in Raw Materials and Supplier Risks: Control Strategies for APIs and Excipients Variability in raw materials and potential risks associated with suppliers have become pressing challenges within pharmaceutical…